Full Press Release Details
BridgeBio Pharma's Gene Therapy Subsidiaries Enter Strategic Partnership With Catalent For Dedicated Gene Therapy Development And Manufacturing Capacity.
BBIO
BridgeBio Pharma's Gene Therapy Subsidiaries Enter Strategic Partnership With Catalent For Dedicated Gene Therapy Development And Manufacturing Capacity
Key Takeaway: BridgeBio Pharma's Gene Therapy Subsidiaries Enter Strategic Partnership With Catalent For Dedicated Gene Therapy Development And Manufacturing Capacity